Description
A DNA alkylating agent; inhibits growth of SKW-3, Reh, CML-T1, BV-173, and HL-60 leukemia cell lines (IC50s = 27.0, 28.6, 15.6, 20.8, and 57.7 μM, respectively) but not MCF-7 and MDA-MB-231 breast cancer cell lines (IC50s = >200 and >200 μM, respectively); kills B-CLL cells derived from naïve and bendamustine-pretreated patients (LD50s= 6.8-8.3 and 3.8-4.9 mg/ml, respectively); inhibits tumor growth by 9% and 96% alone and in combination with ofatumumab, respectively, in a JVM-3 CLL mouse xenograft model (50 mg/kg)
Formal name: 5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid, monohydrochloride
Synonyms: SDX-105
Molecular weight: 394.7
CAS: 3543-75-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|DNA Alkylating Agents||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|DNA Damage and Repair